Naturally-occurring bioactive flavonoids such as diosmin significantly reduces amyloid beta (Aβ) associated pathology in Alzheimer's disease (AD) mouse models. In the present study, oral administration of diosmin reduced cerebral Aβ oligomer levels, tau-hyperphosphorylation and cognitive impairment in the 3xTg-AD mouse model through glycogen synthase kinase-3 (GSK-3) and transient receptor potential canonical 6-related mechanisms. Diosmetin, one major bioactive metabolite of diosmin, increased inhibitory GSK-3β phosphorylation, while selectively reducing γ-secretase activity, Aβ generation, tau hyperphosphorylation and pro-inflammatory activation of microglia in vitro, without altering Notch processing. Therefore, both diosmin and diosmetin could be considered as potential candidates for novel anti-AD therapy.
Introduction
Amyloid-β (Aβ) peptide generation and aggregation as plaques are key pathological events in the development of Alzheimer's disease (AD) (Funamoto et al., 2004; Golde et al., 2000; Huse and Doms, 2000; Sambamurti et al., 2002; Selkoe et al., 1996) , as they are reported as mediators of apoptosis (LaFerla et al., 1995; Loo et al., 1993) , inflammation (Bradt et al., 1998; Suo et al., 1998) , and oxidative stress (Hensley et al., 1994; Murakami et al., 2005) . Aβ peptides are produced via the amyloidogenic pathway of amyloid precursor protein (APP) proteolysis, which involves the concerted efforts of β and γ-secretases (Schenk et al., 1995; Selkoe et al., 1996) . Initially, β-secretase (BACE1) cleaves APP, creating an Aβ-containing carboxyl terminal fragment, known as β-C-terminal fragment (β-CTF) or C99 (Sinha and Lieberburg, 1999; Vassar et al., 1999; Yan et al., 1999) , and an amino-terminal, soluble APP-β (sAPP-β) fragment, which is released extracellularly. Intracellularly, β-CTF is then cleaved by a multi-protein γ-secretase complex that results in generation of the Aβ peptide and a smaller γ-CTF, also known as C57 (De Strooper et al., 1998; Steiner et al., 1999) . Neurofibrillary tangles (NFTs), consisting of misfolded and hyperphosphorylated tau (a microtubule protein), have also been implicated as a central pathological feature of AD (Braak et al., 1993; Jellinger, 1998) . The accumulation of Aβ can adversely affect distinct molecular pathways, thus facilitating tau phosphorylation, aggregation, and accumulation of NFTs (Lee and Trojanowski, 2006) . Indeed, Aβ and NFTs synergize to accelerate neurodegenerative processes involved in abnormal metabolism, cellular toxicity, mitochondrial dysfunction, and neuritic plaque formation (Lee and Trojanowski, 2006) .
The intense search for small-molecular compounds that may modulate AD pathology has advanced the analysis of specific dietary-derived substances from fruits and vegetables, which have been suggested to be beneficial against neurodegeneration and aging (Barberger- Gateau et al., 2007; Dai et al., 2006) . In this regard, a group of polyphenols categorized as flavonoids has been recently found to be potentially antiamyloidogenic (Marambaud et al., 2005; Rezai-Zadeh et al., 2005; Yang et al., 2005) . We previously found that the flavonoid luteolin significantly reduces Aβ generation in murine N2a cells expressing the "Swedish" mutant form of APP as well as primary neuronal cells derived from "Swedish" mutant APP overexpressing mice (Tg2576 mouse), via
